Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 131, Issue 4, 2005, Pages 483-486

  Giebel, Sebastian ^a   Locatelli, Franco ^b   Wojnar, Jerzy ^a   Velardi, Andrea ^c   Mina, Tommaso ^b   Giorgiani, Giovanna ^b   Krawczyk Kulis, Malgorzata ^a   Markiewicz, Miroslaw ^a   Wylezol, Iwona ^a   Holowiecki, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Human leucocyte antigen C; Killer immunoglobulin like receptor ligand; Relapse; Survival; Unrelated donor haematopoietic stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE; THYMOCYTE ANTIBODY; IMMUNOGLOBULIN RECEPTOR; KIR2DL1 PROTEIN, HUMAN; LIGAND;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; FEMALE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOSITY; HIGH RISK PATIENT; HLA MATCHING; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROBABILITY; RECIPIENT; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE BODY RADIATION; BLOOD DISEASE; GENETICS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HOMOZYGOTE; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; INFANT; LIGANDS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; RECURRENCE; SURVIVAL ANALYSIS;

EID: 33644806244     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05797.x     Document Type: Article

References (12)

1. Beelen D.W. Ottinger H. Ferencik S. Elmaagacli A.H. Peceny R. Trenschel R. Grosse-Wilde H. ( 2005) Genotypic inhibitory killer immunoglobulin-like receptor incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood, 105, 2594 2600.
2. Cook M.A. Milligan D.W. Fegan C.D. darbyshire P.J. Mahendra P. Craddock C.F. Moss P.A. Briggs D.C. ( 2004) The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood, 103, 1521 1526.
3. Dupont B. Hsu K.C. ( 2004) Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Current Opinion in Immunology, 16, 1 10.
4. Gazit R. Garty B.Z. Monselise Y. Hoffer V. Filkenstein Y. Markel G. Katz G. Hanna J. Achdout H. Gruda R. Gonen-Gross T. Mandelboim O. ( 2004) Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood, 103, 1965 1966.
5. Giebel S. Locatelli F. Lamparelli T. Velardi A. Davies S. Frumento G. Maccario R. Bonetti F. Wojnar J. Martinelli M. Frassoni F. Giorgiani G. Bacigalupo A. Holowiecki J. ( 2003) Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood, 102, 814 819.
6. Hsu K.C. Liu X. Selvakumar A. Mickelson E. O'Reilly R.J. Dupont B. ( 2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of Immunology, 169, 5123 5134.
7. Hsu K.C. Keever-Taylor C.A. Wilton A. Pinto C. Heller G. Arkun K. O'Reilly R.J. Horowitz M.M. Dupont B. ( 2005) Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes. Blood, 105, 4878 4884.
8. Leung W. Iyengar R. Turner V. Lang P. Bader P. Conn P. Niethammer D. Handgretinger R. ( 2004) Determinants of antileukemia effects of allogeneic NK cells. Journal of Immunology, 172, 644 650.
9. Mandelboim O. Reyburn H.T. Sheu E.G. Vales-Gomez M. Davis D.M. Pazmany L. Strominger J.L. ( 1997) The binding site of NK receptors on HLA-C molecules. Immunity, 6, 341 350.
10. Parham P. ( 2004) Immunology. NK cells lose their inhibition. Science, 305, 786 787.
11. Ruggeri L. Capanni M. Urbani E. Perruccio K. Shlomchik W.D. Tosti A. Posati S. Rogaia D. Frassoni F. Aversa F. Martelli M.F. Velardi A. ( 2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science, 295, 2097 2100.
12. Shilling H.G. Young N. Guethlein L.A. Cheng N.W. Gardiner C.M Tyan D. Parham P. ( 2002) Genetic control of human NK cell repertoire. Journal of Immunology, 169, 239 247.